Related Experiment Video
Updated: Jun 1, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
Degradation of the disease-associated prion protein by a serine protease from lichens
Christopher J Johnson1, James P Bennett, Steven M Biro
1Prion Research Laboratory, United States Geological Survey National Wildlife Health Center, Madison, Wisconsin, United States of America. cjjohnson@usgs.gov
Abstract:
The disease-associated prion protein (PrP(TSE)), the probable etiological agent of the transmissible spongiform encephalopathies (TSEs), is resistant to degradation and can persist in the environment. Lichens, mutualistic symbioses containing fungi, algae, bacteria and occasionally cyanobacteria, are ubiquitous in the environment and have evolved unique biological activities allowing their survival in challenging ecological niches. We investigated PrP(TSE) inactivation by lichens and found acetone extracts of three lichen species (Parmelia sulcata, Cladonia rangiferina and Lobaria pulmonaria) have the ability to degrade prion protein (PrP) from TSE-infected hamsters, mice and deer. Immunoblots measuring PrP levels and protein misfolding cyclic amplification indicated at least two logs of reductions in PrP(TSE). Degradative activity was not found in closely related lichen species or in algae or a cyanobacterium that inhabit lichens. Degradation was blocked by Pefabloc SC, a serine protease inhibitor, but not inhibitors of other proteases or enzymes. Additionally, we found that PrP levels in PrP(TSE)-enriched preps or infected brain homogenates are also reduced following exposure to freshly-collected P. sulcata or an aqueous extract of the lichen. Our findings indicate that these lichen extracts efficiently degrade PrP(TSE) and suggest that some lichens could have potential to inactivate TSE infectivity on the landscape or be a source for agents to degrade prions. Further work to clone and characterize the protease, assess its effect on TSE infectivity and determine which organism or organisms present in lichens produce or influence the protease activity is warranted.
Insights
Certain lichen extracts effectively degrade disease-associated prion protein (PrP(TSE)), offering potential for environmental inactivation of transmissible spongiform encephalopathies (TSEs). Further research is needed to identify the specific protease responsible.
Area of Science:
- Environmental microbiology
- Biochemistry
- Prion biology
Background:
- Disease-associated prion protein (PrP(TSE)) is the likely cause of transmissible spongiform encephalopathies (TSEs).
- PrP(TSE) is environmentally persistent and resistant to degradation.
- Lichens are ubiquitous symbiotic organisms with unique survival adaptations.
Purpose of the Study:
- To investigate the potential of lichens to inactivate PrP(TSE).
- To identify lichen species and extracts capable of degrading PrP(TSE).
- To characterize the mechanism of PrP(TSE) degradation by lichens.
Main Methods:
- Acetone and aqueous extracts of three lichen species (Parmelia sulcata, Cladonia rangiferina, Lobaria pulmonaria) were tested for PrP(TSE) degradation.
- Immunoblots and protein misfolding cyclic amplification were used to quantify PrP levels.
- Protease inhibitors were used to identify the class of enzyme responsible for degradation.
Main Results:
- Acetone extracts of P. sulcata, C. rangiferina, and L. pulmonaria degraded PrP(TSE) by at least two logs.
- Degradative activity was specific to these lichen species and not observed in related algae or cyanobacteria.
- Degradation was inhibited by a serine protease inhibitor (Pefabloc SC), indicating a serine protease is involved.
- Freshly-collected P. sulcata and its aqueous extract also reduced PrP levels in infected brain homogenates.
Conclusions:
- Certain lichen extracts possess potent PrP(TSE) degradation capabilities.
- Lichens may play a role in TSE inactivation in the environment.
- Lichen-derived proteases represent a potential source for developing agents to degrade prions.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Export of Misfolded Proteins out of the ER
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

